Daybreak will now have access to the e-prescribing platform's clinicians, prescribers & HME provider locations in the hopes of streamlining the diagnosis & treatment processes of obstructive sleep apnea

LOS ANGELES—Daybreak, a sleep apnea solutions company, has joined Parachute Health, an e-prescribing platform for home medical equipment (HME). Daybreak said this marks its first entry into e-prescribing and makes it available to the more than 300,000 clinicians and prescribers and 3,000 HME provider locations nationwide who use Parachute Health.

Tyler Reddick will share his own personal experiences with obstructive sleep apnea at various NASCAR races for the next few months

SAN DIEGO—Resmed, a health technology company focused on sleep, breathing and care delivered in the home, announced a new collaboration with 23XI Racing and its NASCAR Cup Series driver Tyler Reddick to encourage more people to recognize the signs of sleep apnea and seek diagnosis and treatment.

Carol Burt will take over the role of lead director effective Nov. 15 following the retirement of Ron Taylor

SAN DIEGO—Resmed announced that Carol Burt will become lead director on Sunday, Nov. 15. She will succeed Ron Taylor, Resmed's current lead director, who is not standing for reelection at the company's annual meeting on Nov. 18 and will retire after more than 21 years of service to the company.

The new consumer sleep health platform brings together CPAP.com, The CPAP shop, Lofta & sleeping.com

NEW YORK—Cathay Capital announced the launch of ReDream Brands, a new consumer sleep health platform dedicated to helping millions of people achieve better sleep and healthier lives. The platform brings together four of the industry’s most recognized direct-to-consumer brands: cpap.com, The CPAP Shop, Lofta and sleeping.com, creating a platform for cash-pay obstructive sleep apnea (OSA) customers across North America.



The company said the availability of the devices will help address critical care gaps

MURRYSVILLE, Pennsylvania—Philips, a provider of sleep health technology, announced that Philips Respironics DreamStation BiPAP AVAPS devices are available for sale in the United States for new set-ups for patients with obstructive sleep apnea (OSA) and respiratory impairment, who are both >7 years of age and weighing 40-66 pounds.


Schwartz is an executive with more than two decades of experience

SAN DIEGO, California—Resmed, a provider in health technology focused on sleep, breathing and care delivered in the home, announced the appointment of Salli Schwartz as chief investor relations officer, effective April 21, 2025. In this role, Schwartz will lead Resmed's global investor relations function and report to Mick Farrell, chairman of the board and CEO.